[go: up one dir, main page]

PL2626068T3 - Paracetamol do podawania pozajelitowego - Google Patents

Paracetamol do podawania pozajelitowego

Info

Publication number
PL2626068T3
PL2626068T3 PL13160470.4T PL13160470T PL2626068T3 PL 2626068 T3 PL2626068 T3 PL 2626068T3 PL 13160470 T PL13160470 T PL 13160470T PL 2626068 T3 PL2626068 T3 PL 2626068T3
Authority
PL
Poland
Prior art keywords
paracetamol
parenteral administration
parenteral
administration
Prior art date
Application number
PL13160470.4T
Other languages
English (en)
Inventor
Achleitner Georg
David Dasberg
Christiane Aichholzer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41066778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2626068(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL2626068T3 publication Critical patent/PL2626068T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13160470.4T 2009-04-22 2010-04-19 Paracetamol do podawania pozajelitowego PL2626068T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20090005630 EP2243477A1 (de) 2009-04-22 2009-04-22 Paracetamol zur parenteralen Verabreichung

Publications (1)

Publication Number Publication Date
PL2626068T3 true PL2626068T3 (pl) 2016-09-30

Family

ID=41066778

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13160470.4T PL2626068T3 (pl) 2009-04-22 2010-04-19 Paracetamol do podawania pozajelitowego
PL10714862T PL2421522T3 (pl) 2009-04-22 2010-04-19 Paracetamol do podawania pozajelitowego

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL10714862T PL2421522T3 (pl) 2009-04-22 2010-04-19 Paracetamol do podawania pozajelitowego

Country Status (12)

Country Link
US (2) US8741959B2 (pl)
EP (3) EP2243477A1 (pl)
JP (1) JP2012524738A (pl)
CN (1) CN102421426A (pl)
AU (1) AU2010238854B2 (pl)
BR (1) BRPI1011630B8 (pl)
DK (2) DK2626068T3 (pl)
ES (2) ES2415354T3 (pl)
HU (1) HUE026823T2 (pl)
PL (2) PL2626068T3 (pl)
PT (1) PT2421522E (pl)
WO (1) WO2010121762A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121154A1 (it) 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
EA028075B1 (ru) * 2014-04-29 2017-10-31 Мыкола Ивановыч ГУМЕНЮК Фармацевтическая композиция
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
US20170202793A1 (en) * 2014-07-25 2017-07-20 Terumo Kabushiki Kaisha Packaged acetaminophen injection solution preparation
EP3120837A1 (de) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Verfahren zur herstellung einer bortezomibester-lösung
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE279405C (pl) 1913-11-29 1914-10-19
DD279405A1 (de) 1989-01-10 1990-06-06 Berlin Chemie Veb Verfahren zur herstellung eines parenteral applizierbaren analgetikums/antipyretikums
KR930011994B1 (ko) * 1991-08-16 1993-12-23 대광제약 주식회사 파라세타몰의 생체이용율을 높이는 방법 및 이 생체이용율이 높아진 파라세타몰을 함유한 제제
US5252313A (en) 1991-12-20 1993-10-12 Colgate-Palmolive Company Visually clear gel dentifrice
JP3913795B2 (ja) * 1995-09-28 2007-05-09 エスエス製薬株式会社 安定な解熱鎮痛剤配合液剤
JPH09286724A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 経口用安定液剤
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
DE69719189T2 (de) 1997-11-18 2003-11-27 Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
JPH11279046A (ja) * 1998-03-30 1999-10-12 Shiseido Co Ltd 皮膚外用剤
IT1301976B1 (it) * 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
IT1313579B1 (it) * 1999-07-30 2002-09-09 Acraf Composizione farmaceutica liquida a base di paracetamolo.
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
KR100405161B1 (ko) * 2000-12-14 2003-11-12 신풍제약주식회사 록소프로펜 함유 근육주사제 조성물
DE10112325A1 (de) 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
EP1469885A1 (en) 2001-12-18 2004-10-27 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Parenteral composition of paracetamol
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
JP4358535B2 (ja) * 2003-03-05 2009-11-04 昭和薬品化工株式会社 アセトアミノフェンを含有する安定な水性医薬組成物
EA015336B1 (ru) 2005-06-03 2011-06-30 Элан Фарма Интернэшнл Лтд. Стабильная композиция с наночастицами ацетаминофена
DE102005037653A1 (de) 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
WO2008009756A1 (es) 2006-07-18 2008-01-24 Genfarma Laboratorio S.L. Formulación líquida inyectable de paracetamol
CN101015542A (zh) * 2007-02-13 2007-08-15 天津生机集团有限公司 家畜用复方对乙酰氨基酚注射液及其制备方法
EP1992334A1 (en) * 2007-05-08 2008-11-19 Docpharma NV/SA Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
EP2170313A2 (en) * 2007-06-18 2010-04-07 Combino Pharm, S.L. Aqueous formulations of acetaminophen for injection
US9399012B2 (en) * 2007-11-13 2016-07-26 Mallinckrodt Ip Reduced dose intravenous acetaminophen
EP2307056B1 (en) * 2008-01-17 2021-12-15 Pharmis Biofarmacêutica, LDA Stabilized aqueous formulation containing paracetamol
CN101366695A (zh) * 2008-10-16 2009-02-18 江苏四环生物股份有限公司 扑热息痛注射液及其制备方法
CN102711726A (zh) * 2009-12-10 2012-10-03 特克尼梅德医疗技术股份公司 用于制备扑热息痛稳定液体制剂的方法和组合物

Also Published As

Publication number Publication date
BRPI1011630B8 (pt) 2021-05-25
US8741959B2 (en) 2014-06-03
AU2010238854B2 (en) 2015-04-30
EP2626068A1 (de) 2013-08-14
US20150105471A1 (en) 2015-04-16
AU2010238854A1 (en) 2011-11-17
HK1166957A1 (en) 2012-11-16
BRPI1011630B1 (pt) 2020-06-23
CN102421426A (zh) 2012-04-18
WO2010121762A1 (de) 2010-10-28
PT2421522E (pt) 2013-07-08
EP2421522B1 (de) 2013-04-03
BRPI1011630A2 (pt) 2016-03-22
US20120035267A1 (en) 2012-02-09
DK2626068T3 (en) 2016-02-29
EP2421522A1 (de) 2012-02-29
HUE026823T2 (en) 2016-07-28
EP2626068B1 (de) 2015-12-09
ES2415354T3 (es) 2013-07-25
ES2564547T3 (es) 2016-03-23
EP2243477A1 (de) 2010-10-27
DK2421522T3 (da) 2013-07-08
PL2421522T3 (pl) 2013-08-30
JP2012524738A (ja) 2012-10-18

Similar Documents

Publication Publication Date Title
GB0907534D0 (en) Injection devices
PT2389212T (pt) Seringa
GB0909680D0 (en) Dosage form
LT3184136T (lt) Injektorius
TWM391239U (en) Improved structure for earphone
IL210393A0 (en) Administration regime for nitrocatechols
EP2575887A4 (en) CONJUGATES OF OPTIMIZED MEDICINES
AP2012006407A0 (en) Syringes
GB0913171D0 (en) Adjustable shim
IL215265A0 (en) Syringe for single use
GB0922589D0 (en) Pharmaceutical compounds
GB0910088D0 (en) Location arrangements
PL2626068T3 (pl) Paracetamol do podawania pozajelitowego
EP2470190A4 (en) ECHINOCANDINDERIVATE
EG26793A (en) Medical Injector
GB0915249D0 (en) Drug carrier
GB0915319D0 (en) Combination medicament
GB0908905D0 (en) Pharmaceutical compounds
EP2521539A4 (en) INJECTABLE PREPARATIONS FOR PARENTERAL ADMINISTRATION
GB0922316D0 (en) Syringe
GB0916368D0 (en) Document displayer
GB0901902D0 (en) Medicament
GB0903318D0 (en) Medicament
GB0915607D0 (en) Medication monitor
GB0910772D0 (en) Pharmaceutical